Fred Jacobs is a highly accomplished CEO, entrepreneur, and industry leader in the field of oncology. With a Bachelor of Science in Economics, Accounting from the University of Maryland, Jacobs' extensive experience spans multiple organizations, including Tyg Oncology, Astrimmune, and Iqudos.

As the Chief Executive Officer and Co-Founder of Tyg Oncology, Jacobs combines his passion for business, oncology, and entrepreneurial spirit to lead the company. He has previously served as the Chief Executive Officer at Astrimmune and Iqudos, where he demonstrated his expertise in managing healthcare and biotech companies. Jacobs has also previously held executive positions at Island Care and Aphton Corporation.

Jacobs' professional background includes regulatory compliance and risk management. He served as a Legal Services Panel Member at Icaew and Director of Inspection and Investigation at Solicitors Regulation Authority for England and Wales. Jacobs also served as an Auditor at Pwc Papua New Guinea.

Overall, Jacobs is a seasoned industry professional with extensive experience across multiple domains. He continues to inspire others in the oncology and biotechnology industry through his achievements and leadership skills.